The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.EBI
University of South Florida
5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species.EBI
Universit£
Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.EBI
Kyowa Hakko Kogyo
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.EBI
Kyowa Hakko Kogyo
8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.EBI
Kyowa Hakko Kogyo
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.EBI
Niddk
2-(N'-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators.EBI
University of South Florida
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure.EBI
Kyowa Hakko Kogyo
2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor.EBI
University of South Florida
Structure-affinity relationships of 5'-aromatic ethers and 5'-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents.EBI
Cv Therapeutics
The discovery and synthesis of highly potent, A2a receptor agonists.EBI
Glaxowellcome Medicines Research Centre
 
Adenosine A2A antagonists with potent anti-cataleptic activityEBI
TBA
 
Discovery of FK453, a novel non-xanthine adenosine A1 receptor antagonistEBI
TBA
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon.EBI
St. John'S University
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine.EBI
Cv Therapeutics
Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and quantum chemical studies.EBI
Università
Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.EBI
Hokuriku University
8-(Dicyclopropylmethyl)-1,3-dipropylxanthine: a potent and selective adenosine A1 antagonist with renal protective and diuretic activities.EBI
Kyowa Hakko Kogyo
(E)-1,3-dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists.EBI
Kyowa Hakko Kogyo
2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators.EBI
University of South Florida
7,8-Dihydro-8-ethyl-2-(3-noradamantyl)-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one: a potent and water-soluble adenosine A1 antagonist.EBI
Kyowa Hakko Kogyo
Effects of alkyl substitutions of xanthine skeleton on bronchodilation.EBI
Hokuriku University
Identification of a fragment-like small molecule ligand for the methyl-lysine binding protein, 53BP1.BDB
University of North Carolina At Chapel Hill